ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH
Our various research projects have moved forward, in particular the Bench-to-Bedside Head and Neck Cancer Research Programme at UCL Cancer Institute. We are also working to continue to improve awareness of HPV-associated oropharyngeal cancer through public health education.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves stood at £53,723, with a stated policy target of holding reserves equivalent to two years of possible commitments. The trustees note that while current funds are sufficient to achieve aims, securing ongoing income is a significant risk to continuing the charity's expansion.
What the accounts disclose
“Year on year the charity hopes to increase the reserves to be in line with 2 years possible commitments”
“At present funds are sufficient to achieve the aims set, but more funding needs to be sought to continue to expand our work.”
“the company KARL STORZ has continued to support our programme.”
Trustees
- Dr MATT LECHNER MD PhDFRCSchair
- FRANCIS VAZ FRCS
- PROFESSOR VALERIE LUND CBE
- Professor Paul O'Flynn
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £105k | £93k |
| 31/07/2024 | £105k | £93k |
| 24/07/2023 | £2k | £7k |
| 24/07/2022 | £4k | £5k |
| 24/07/2021 | £7k | £344 |
Common questions
Is ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £53,723, with a stated policy target of holding reserves equivalent to two years of possible commitments. The trustees note that while current funds are sufficient to achieve aims, securing ongoing income is a significant risk to continuing the charity's expansion.